Replies to post #16881 on Momenta Pharmaceuticals, Inc. (MNTA)

[jbog]

These numbers, in hindsight show how asinine Momenta has been about dilution.

[DewDiligence]

MNTA’s 3/31/17 pro forma cash balance was $470.9M—a decrease of $14.7M relative to the $485.6M pro forma cash balance on 12/30/16 (#msg-128997593)

The $470.9M figure consists of: $469.5M of current assets on the 3/31/17 balance sheet (https://www.sec.gov/Archives/edgar/data/1235010/000123501017000012/mnta1q201710-q.htm#s5879ED69BA6459F1A121EC5308C63CE0 ); $21.8M of restricted cash (ibid); $36.9M raised from the ATM facility between 4/1/17 and 5/3/17 (ibid, page 22); less $57.3M in current liabilities (not counting the “deferred revenue” line, which is not a true liability).